Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    cdc7
Show Display Options
Rank Status Study
1 Terminated A Study of BMS-863233 in Patients With Hematologic Cancer
Condition: Refractory Hematologic Cancer
Intervention: Drug: Cdc7-inhibitor (BMS-863233)
2 Terminated A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors
Conditions: Advanced Solid Cancers;   Metastatic Cancer
Intervention: Drug: Cdc7-inhibitor
3 Terminated Study of NMS-1116354 in Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: NMS-1116354
4 Terminated Study of NMS-1116354 in Advanced/Metastatic Solid Tumors
Condition: Advanced/Metastatic Solid Tumors
Intervention: Drug: NMS-1116354
5 Recruiting A Study to Evaluate TAK-931 in Participants With Advanced Nonhematologic Tumors
Condition: Nonhematologic Neoplasms, Advanced
Intervention: Drug: TAK-931

Study has passed its completion date and status has not been verified in more than two years.